title: Neurogenic bladder: from diagnosis to management.
abstract: Patients with spinal cord injury (SCI) present with a wide range and variety of urologic manifestations, depending upon the level of injury. Historically, patients with spinal cord injury experienced significant mortality related to renal failure. Greater knowledge of the pathophysiology of SCI, however, has contributed to a reduction in mortality. It is essential to perform a thorough initial evaluation and regular follow-up of these patients to achieve the primary goal of preservation of renal function, with the secondary goal of optimizing the patient's quality of life.
authors.affiliation: University of Southern California, Los Angeles, CA, USA.
authors.forename: Ellen
authors.initials: E
authors.lastname: Goldmark
authors.forename: Benjamin
authors.initials: B
authors.lastname: Niver
authors.forename: David A
authors.initials: DA
authors.lastname: Ginsberg
mesh_terms: D000083:Acetanilides / Q000627:therapeutic use; D058667:Adrenergic beta-3 Receptor Agonists / Q000627:therapeutic use; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use; D002408:Catheters, Indwelling; D006801:Humans; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D009465:Neuromuscular Agents / Q000627:therapeutic use; D019651:Plastic Surgery Procedures; D013119:Spinal Cord Injuries / Q000150:complications*; D013844:Thiazoles / Q000627:therapeutic use; D014521:Urethra / Q000601:surgery*; D001743:Urinary Bladder / Q000601:surgery*; D001750:Urinary Bladder, Neurogenic / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D014546:Urinary Catheterization / Q000379:methods; D014547:Urinary Diversion; D014563:Urodynamics
chemical_list: D000083:Acetanilides; D058667:Adrenergic beta-3 Receptor Agonists; D018727:Muscarinic Antagonists; D009465:Neuromuscular Agents; D013844:Thiazoles; D019274:Botulinum Toxins, Type A; C520025:mirabegron